141 related articles for article (PubMed ID: 12022882)
1. Role of basic residues of the autolysis loop in the catalytic function of factor Xa.
Manithody C; Yang L; Rezaie AR
Biochemistry; 2002 May; 41(21):6780-8. PubMed ID: 12022882
[TBL] [Abstract][Full Text] [Related]
2. Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex.
Manithody C; Rezaie AR
Biochemistry; 2005 Aug; 44(30):10063-70. PubMed ID: 16042383
[TBL] [Abstract][Full Text] [Related]
3. Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysis.
Cook BC; Rudolph AE; Kurumbail RG; Porche-Sorbet R; Miletich JP
J Biol Chem; 2000 Dec; 275(49):38774-9. PubMed ID: 10995746
[TBL] [Abstract][Full Text] [Related]
4. Sodium binding site of factor Xa: role of sodium in the prothrombinase complex.
Rezaie AR; He X
Biochemistry; 2000 Feb; 39(7):1817-25. PubMed ID: 10677232
[TBL] [Abstract][Full Text] [Related]
5. Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin.
Rezaie AR; Yang L
Biochim Biophys Acta; 2001 Oct; 1528(2-3):167-76. PubMed ID: 11687304
[TBL] [Abstract][Full Text] [Related]
6. Definition of a factor Va binding site in factor Xa.
Rudolph AE; Porche-Sorbet R; Miletich JP
J Biol Chem; 2001 Feb; 276(7):5123-8. PubMed ID: 11087737
[TBL] [Abstract][Full Text] [Related]
7. Pentasaccharide enhances the inactivation of factor Xa by antithrombin by promoting the assembly of a Michaelis-type intermediate complex. Demonstration by rapid kinetic, surface plasmon resonance, and competitive binding studies.
Rezaie AR
Biochemistry; 2006 Apr; 45(16):5324-9. PubMed ID: 16618121
[TBL] [Abstract][Full Text] [Related]
8. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.
Rezaie AR
J Biol Chem; 2000 Feb; 275(5):3320-7. PubMed ID: 10652320
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
Gale AJ; Yegneswaran S; Xu X; Pellequer JL; Griffin JH
J Biol Chem; 2007 Jul; 282(30):21848-55. PubMed ID: 17553804
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
Rezaie AR; Yang L; Manithody C
Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
[TBL] [Abstract][Full Text] [Related]
11. The critical role of the 185-189-loop in the factor Xa interaction with Na+ and factor Va in the prothrombinase complex.
Rezaie AR; Kittur FS
J Biol Chem; 2004 Nov; 279(46):48262-9. PubMed ID: 15347660
[TBL] [Abstract][Full Text] [Related]
12. Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.
Chen L; Manithody C; Yang L; Rezaie AR
Protein Sci; 2004 Feb; 13(2):431-42. PubMed ID: 14739327
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
[TBL] [Abstract][Full Text] [Related]
14. Heparin-binding exosite of factor Xa.
Rezaie AR
Trends Cardiovasc Med; 2000 Nov; 10(8):333-8. PubMed ID: 11369259
[TBL] [Abstract][Full Text] [Related]
15. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
16. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
Rezaie AR; Manithody C; Yang L
J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
[TBL] [Abstract][Full Text] [Related]
17. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
[TBL] [Abstract][Full Text] [Related]
18. Role of the N-terminal epidermal growth factor-like domain of factor X/Xa.
Kittur FS; Manithody C; Rezaie AR
J Biol Chem; 2004 Jun; 279(23):24189-96. PubMed ID: 15069066
[TBL] [Abstract][Full Text] [Related]
19. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
[TBL] [Abstract][Full Text] [Related]
20. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
Mast AE; Broze GJ
Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
